{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Updates and Approvals: 2016 in Review

Purpose of Activity

To provide clinical information about six drugs approved by the FDA in 2016.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify the indications and mechanism of action for six new drugs.
  2. Discuss the dosing, contraindications, and warnings related to each drug.
Price: $21.95

Credits:

  • ANCC 2.0 CH / 2.0 APH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours







Test Code: NP1216A
Published: Dec 2016
Expires: 12/4/2020
Passing Score: 14/20 (70%)
Authors: Lindsy Meadowcraft, PharmD, BCACP, CDE; Geoffrey Mospan, PharmD, BCPS; Taylor Morrisette; Katie Smart; Melissa Janis